About
Cell Medica develops and manufactures engineered cell therapies to treat cancer and infectious diseases, focusing on autologous T-cell immunotherapies.
Explore Cell Medica's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.